Need all Congresses? Press Enter for expanded federal results.

Prescription drugs

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
332
Coverage
110th-119th
Current view
115th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
332 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HCONRES 146
Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescript...
115th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 20, 2018
HCONRES 136
Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and p...
115th Referred to the House Committee on Energy and Commerce. September 13, 2018
HR 7369
DEA Notification Act of 2018
115th Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 20, 2018
HR 7348
Affordable Drug Manufacturing Act of 2018
115th Referred to the House Committee on Energy and Commerce. December 19, 2018
HR 7339
Medicare for America Act of 2018
115th Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, Education and the Workforce, Natural Resources, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 19, 2018
HR 7328
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
115th Received in the Senate. December 20, 2018
HR 7324
Preserving Access to Orphan Drugs Act of 2018
115th Referred to the Subcommittee on Health. January 2, 2019
HR 7266
To require the Secretary of Health and Human Services to consider the Margaret R. Pardee Memorial Hospital as a covered entity fo...
115th Referred to the House Committee on Energy and Commerce. December 12, 2018
HR 7251
Hatch-Waxman Integrity Act of 2018
115th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 11, 2018
HR 7249
Better Prior Authorization Notification Act
115th Referred to the Subcommittee on Health. December 17, 2018
HR 7223
Right Rebate Act of 2018
115th Referred to the Subcommittee on Health. December 13, 2018
HR 7217
IMPROVE Act
115th Received in the Senate. December 12, 2018
HR 7124
Keeping All Students Safe Act
115th Referred to the Subcommittee on Military Personnel. November 15, 2018
HR 7001
CAPS for Prescriptions Act
115th Referred to the Subcommittee on Health. October 12, 2018
HR 6958
Drug Price Transparency Act
115th Referred to the Subcommittee on Health. October 10, 2018
HR 6848
VA Safe Opioid Return Act
115th Referred to the Subcommittee on Health. September 20, 2018
HR 6733
Know the Cost Act of 2018
115th Referred to the Subcommittee on Health. September 13, 2018
HR 6712
Warrior Wellness Act
115th Referred to the Subcommittee on Military Personnel. September 6, 2018
HR 6688
ALERT Act of 2018
115th Referred to the Subcommittee on Health. August 31, 2018
HR 6642
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innova...
115th Referred to the Subcommittee on Health. August 3, 2018
HR 6641
COST Act
115th Referred to the Subcommittee on Health. August 17, 2018
HR 6608
Prescription Drug Monitoring Program Best Practices Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6593
Medication Automated Quotation System, or MEDAQ, Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6577
PRICED Act
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6575
Medicare Prescription Drug Savings and Choice Act of 2018
115th Referred to the Subcommittee on Health. August 13, 2018
HR 6574
Medicare Fair Drug Pricing Act of 2018
115th Referred to the Subcommittee on Health. August 13, 2018
HR 6563
Lower Out-of-Pocket Costs for Seniors Act
115th Referred to the Subcommittee on Health. August 9, 2018
HR 6562
FORWARD Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6505
Medicare Negotiation and Competitive Licensing Act of 2018
115th Referred to the Subcommittee on Health. August 3, 2018
HR 6488
SAVE Act
115th Referred to the Subcommittee on Health. August 8, 2018
HR 6478
Biosimilars Competition Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6340
Capping Prescription Costs Act of 2018
115th Referred to the House Committee on Energy and Commerce. July 11, 2018
HR 6294
REVAMP Act
115th Referred to the House Committee on Energy and Commerce. June 28, 2018
HR 6291
Efficient Drug Disposal Act of 2018
115th Referred to the House Committee on Energy and Commerce. June 28, 2018
HR 6240
Drug Discount Accountability Act
115th Referred to the House Committee on Energy and Commerce. June 27, 2018
HR 6165
COMBAT Act
115th Referred to the Subcommittee on Military Personnel. June 21, 2018
HR 6144
Know the Lowest Price Act of 2018
115th Referred to the Subcommittee on Health. June 27, 2018
HR 6143
Patient Right to Know Drug Prices Act
115th Referred to the House Committee on Energy and Commerce. June 19, 2018
HR 6142
Reducing Drug Waste Act of 2018
115th Referred to the House Committee on Energy and Commerce. June 19, 2018
HR 6133
Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
115th Referred to the House Committee on Energy and Commerce. June 19, 2018